Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
3.220
+0.110 (3.54%)
At close: Nov 4, 2024, 4:00 PM
3.140
-0.080 (-2.48%)
After-hours: Nov 4, 2024, 4:01 PM EST
Vistagen Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
Net Income | -33.19 | -29.36 | -59.25 | -47.76 | -17.93 | -20.77 | |
Depreciation & Amortization | 0.58 | 0.57 | 0.53 | 0.71 | 0.48 | 0.1 | |
Other Amortization | - | - | - | 0.23 | - | - | |
Loss (Gain) From Sale of Assets | 0.01 | 0.01 | - | - | - | - | |
Stock-Based Compensation | 2.77 | 2.18 | 3.34 | 3.48 | 2.31 | 3.93 | |
Other Operating Activities | - | - | 3.64 | - | - | 0.83 | |
Change in Accounts Receivable | - | - | - | - | - | 0.3 | |
Change in Accounts Payable | 1.28 | 0.52 | -0.93 | 1.69 | 0.05 | -0.39 | |
Change in Unearned Revenue | 0.61 | 0.52 | 0.21 | -1 | 3.67 | - | |
Change in Other Net Operating Assets | -0.83 | -0.25 | 2.76 | -2.6 | -0.64 | 0.25 | |
Operating Cash Flow | -28.79 | -25.81 | -49.72 | -45.26 | -12.07 | -15.76 | |
Capital Expenditures | -0.1 | -0.06 | -0.21 | -0.2 | -0.28 | - | |
Cash Acquisitions | - | - | -0.53 | - | - | - | |
Investing Cash Flow | -5.53 | -0.06 | -0.74 | -0.2 | -0.28 | - | |
Short-Term Debt Issued | - | - | - | - | 0.22 | - | |
Total Debt Issued | - | - | - | - | 0.22 | - | |
Short-Term Debt Repaid | - | -0.99 | -1.03 | - | -0.6 | -0.29 | |
Long-Term Debt Repaid | - | - | - | -0 | -0 | -0 | |
Total Debt Repaid | -0.78 | -0.99 | -1.03 | -0 | -0.61 | -0.3 | |
Net Debt Issued (Repaid) | -0.78 | -0.99 | -1.03 | -0 | -0.38 | -0.3 | |
Issuance of Common Stock | 129.47 | 129.39 | 0.17 | 10.49 | 114.48 | 4.01 | |
Other Financing Activities | -1.07 | - | -0.17 | - | - | 0.3 | |
Financing Cash Flow | 127.62 | 128.4 | -1.04 | 10.48 | 114.1 | 4.01 | |
Net Cash Flow | 93.3 | 102.53 | -51.5 | -34.97 | 101.75 | -11.75 | |
Free Cash Flow | -28.89 | -25.87 | -49.93 | -45.46 | -12.35 | -15.76 | |
Free Cash Flow Margin | -2975.70% | -2431.77% | - | -4099.28% | -1133.45% | - | |
Free Cash Flow Per Share | -1.15 | -1.34 | -7.17 | -6.89 | -4.30 | -10.78 | |
Cash Interest Paid | - | - | - | - | 0.01 | 0.01 | |
Cash Income Tax Paid | - | - | - | - | 0 | 0 | |
Levered Free Cash Flow | -18.21 | -18 | -32.74 | -25.98 | -8.07 | -9.02 | |
Unlevered Free Cash Flow | -18.21 | -18 | -32.74 | -26.21 | -8.06 | -9.01 | |
Change in Net Working Capital | -2.39 | 0.05 | -0.64 | 0.34 | -0.64 | 0.04 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.